Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.

Antiviral research - 1 Jul 2024

Franco-May Diana A, Gómez-Carballo Jesús, Barrera-Badillo Gisela, Cruz-Ortíz María N, Núñez-García Tatiana E, Arellano-Suárez Dayanira S, Wong-Arámbula Claudia, López-Martínez Irma, Wong-Chew Rosa M, Ayora-Talavera Guadalupe

Abstract excerpt

The most widely used class of antivirals available for Influenza treatment are the neuraminidase inhibitors (NAI) Oseltamivir and Zanamivir. However, amino acid (AA) substitutions in the neuraminidase may cause reduced inhibition or high antiviral resistance. In Mexico, the current state of knowledge about NAI susceptibility is scarce, in this study we report the results of 14 years of Influenza surveillance by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Influenza A virus
Share to Influenza A Virus, H1N1 Subtype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Influenza A Virus, H3N2 Subtype

Share to Influenza B virus

Share to Influenza, Human

Share to Neuraminidase

Share to Oseltamivir

Share to Zanamivir

Source

Identifiers

PMID: 38795911
DOI: 10.1016/j.antiviral.2024.105918

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.PMID 38795911Read ↗

Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.Semantic proximity Read ↗

Neuraminidase inhibitor resistance in influenza: a clinical perspectiveSemantic proximity Read ↗

Influenza neuraminidase mutations and resistance to neuraminidase inhibitors.Semantic proximity Read ↗

Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceSemantic proximity Read ↗

Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugsSemantic proximity Read ↗

Evolutionary Characteristic of Global H1N1 Influenza A Viruses With Oseltamivir Resistance From 1918 to 2024Semantic proximity Read ↗

Frequency and distribution of H1N1 influenza A viruses with oseltamivir-resistant mutations worldwide before and after the 2009 pandemic.Semantic proximity Read ↗

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008Semantic proximity Read ↗

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015.Semantic proximity Read ↗

Neuraminidase characterisation reveals very low levels of antiviral resistance and the presence of mutations associated with reduced antibody effectiveness in the Irish influenza 2018/2019 season.Semantic proximity Read ↗

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014Semantic proximity Read ↗

Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.